文献速递烧伤创面修复

烧伤临床试验:注册与发表情况的系统综述

Burn clinical trials: A systematic review of registration and publications.
PubMed 文献 · Burns · 2017-11-21

该研究通过检索ClinicalTrials.gov与WHO临床试验注册库(2017年5月)及PubMed等数据库(2017年6月),分析全球烧伤临床试验的注册与发表特征。共识别738项烧伤临床试验,多数为公共资助(77%)且仍在进行(52%);已结束试验中仅69项(28%)发表结果,产业资助试验发表比例显著更低(14% vs 公共资助33%)。报告质量欠佳,试验分期、严重程度和样本量估算报告不足。

要点

  • 全球共识别738项烧伤临床试验,多数为公共资助(77%)且仍在进行(52%)。
  • 已结束试验中仅69项(28%)发表结果,产业资助试验发表比例显著低于公共资助(14% vs 33%)。
  • 报告质量欠佳,试验分期、严重程度和样本量估算是最常报告不足的类别。

核心结论

  • 烧伤临床试验在数量、地域和干预类型上不断增多,但仅小部分发表且报告质量欠佳。
  • 作者建议烧伤研究者应注册并报告所有临床试验 regardless of outcome,并认为优良的先验设计可减少过早终止,强制报告数据字段可提高报告质量。

研究设计与样本

  • 系统综述,检索ClinicalTrials.gov与WHO临床试验注册库(2017年5月)获取试验注册记录,检索PubMed、Google Scholar、OVID MEDLINE和ClinicalTrials.gov(2017年6月)获取发表文献。
  • 采用改编自CONSORT和ICH E3指南的23项评分表评估发表质量。
  • 系统综述注册号:CRD42017068549。

主要发现

  • 共识别全球738项烧伤临床试验,其中多数为公共资助(77%)、正在进行(52%),评估行为、药物、器械、饮食及生物/操作类干预。
  • 已结束试验中69项(28%)发表了研究结果。
  • 产业资助试验发表结果的比例显著低于公共资助试验(14% vs 33%)。
  • 报告质量欠佳,试验分期、严重程度和样本量估算是最常报告不足的类别。

局限性

  • 不完整、过时及未注册的临床试验难以追踪。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized controlled clinical trials (CTs) are gold standard tools for assessing interventions. Although burn CTs have improved care, their status, publication frequency, and publication quality are not known. OBJECTIVES: (1) Characterize burn CTs by analyzing location, completion status, temporal trend, and funding sources. (2) Assess quality of trial reporting. DATA SOURCES: CT records were obtained from ClinicalTrials.gov and WHO's CT Registry (searched May 2017). Publications were obtained from PubMed, Google Scholar, OVID MEDLINE, and ClinicalTrials.gov (searched June 2017). PUBLICATION APPRAISAL: 23-item rubric adapted from CONSORT and ICH E3 guidelines. RESULTS: 738 burn CTs were identified globally, of which majority were publically-funded (77%), ongoing (52%), and assessed behavioral, pharmacological, device-based, dietary-based, and biological/procedural interventions. Amongst the ended trials, 69 (28%) published their findings. Significantly fewer industry-funded trials published findings (14% vs 33% publically-funded). Quality of reporting was suboptimal, and most underreported categories were trial phase, severity, and sample size estimation. LIMITATIONS: Incomplete, outdated, and non-registered CTs which are difficult to track. CONCLUSIONS: Burn trials are proliferating in number, location, and interventions assessed. Only a small proportion are published and quality of reporting is suboptimal. IMPLICATIONS OF KEY FINDINGS: Burn researchers should aim to register and report on all clinical trials regardless of outcome. Superior a priori design can reduce precocious termination and mandatory reporting of data fields can improve quality of reporting. Systematic review registration number: CRD42017068549.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Sinha S, Yoon G, Shin W, et al. Burn clinical trials: A systematic review of registration and publications. Burns. 2017. PMID: 29169699. doi:10.1016/j.burns.2017.11.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。